Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Marinus Pharma CS (MRNS)

Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Marinus Pharmaceuticals: Q3 Earnings Snapshot AP - Tue Nov 12, 3:04PM CST

Marinus Pharmaceuticals: Q3 Earnings Snapshot

MRNS : 0.2572 (+8.07%)
Author
3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity MarketBeat - Fri Oct 11, 8:28AM CDT

Check out these three micro-cap stocks that show big-time potential upside, but also pose face large obstacles to achieving success.

IWC : 130.45 (+1.13%)
LODE : 0.4219 (+9.41%)
AMPX : 1.9000 (unch)
SPY : 601.30 (+1.11%)
MRNS : 0.2572 (+8.07%)
Author
Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech? MarketBeat - Tue Oct 1, 9:48AM CDT

Marinus is an under $2 biotech stock with Wall Street analysts price targets ranging from $2 to $13. Its upcoming trial results have big implications.

MRNS : 0.2572 (+8.07%)
Marinus Pharmaceuticals: Q2 Earnings Snapshot AP - Tue Aug 13, 6:07AM CDT

Marinus Pharmaceuticals: Q2 Earnings Snapshot

MRNS : 0.2572 (+8.07%)
Marinus Pharmaceuticals: Q1 Earnings Snapshot AP - Wed May 8, 6:29AM CDT

Marinus Pharmaceuticals: Q1 Earnings Snapshot

MRNS : 0.2572 (+8.07%)
Marinus Pharmaceuticals: Q4 Earnings Snapshot AP - Tue Mar 5, 3:24PM CST

Marinus Pharmaceuticals: Q4 Earnings Snapshot

MRNS : 0.2572 (+8.07%)
Marinus Pharmaceuticals: Q3 Earnings Snapshot AP - Tue Nov 7, 2023

Marinus Pharmaceuticals: Q3 Earnings Snapshot

MRNS : 0.2572 (+8.07%)
Marinus Pharmaceuticals: Q2 Earnings Snapshot AP - Thu Aug 10, 2023

Marinus Pharmaceuticals: Q2 Earnings Snapshot

MRNS : 0.2572 (+8.07%)
Marinus Pharmaceuticals: Q1 Earnings Snapshot AP - Thu May 11, 2023

Marinus Pharmaceuticals: Q1 Earnings Snapshot

MRNS : 0.2572 (+8.07%)
Marinus Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire - Wed May 3, 2023

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that management will present...

MRNS : 0.2572 (+8.07%)

Barchart Exclusives

3 AI Stocks That Could Each Be Worth $4 Trillion in 2025 Barchart - Wed Dec 25, 6:30AM CST
AI giants Apple, Microsoft, and Nvidia leverage groundbreaking technologies and strong financial growth, positioning themselves as top contenders for $4 trillion market caps by 2025. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot